by Clinical Neuropsychologist Online | Tuesday, March 5, 2024 | Dementia
Abstract INTRODUCTION Magnetic resonance imaging (MRI) biomarkers are needed for indexing early biological stages of Alzheimer’s disease (AD), such as plasma amyloid-β (Aβ42/40) positivity in Aβ positron emission tomography (PET) negative individuals. METHODS...
by Clinical Neuropsychologist Online | Tuesday, March 5, 2024 | Dementia
Dementia, Volume 23, Issue 4, Page 567-583, May 2024. Background. The diagnosis of young-onset dementia presents significant challenges both for the person and their families, which often differ from the challenges faced with late-onset dementia. Evidence of the...
by Clinical Neuropsychologist Online | Saturday, March 2, 2024 | Dementia
Dementia, Volume 23, Issue 4, Page 550-566, May 2024. BackgroundPeople with dementia and unpaid carers need to go through a social care or carers needs assessment to access and receive subsidised or fully-funded social care. With no previous evidence, this qualitative...
by Clinical Neuropsychologist Online | Friday, March 1, 2024 | Dementia
Abstract BACKGROUND Subjective cognitive impairment (SCI) measures in population-based surveys offer potential for dementia surveillance, yet their validation against established dementia measures is lacking. METHODS We assessed agreement between SCI and a validated...
by Clinical Neuropsychologist Online | Friday, March 1, 2024 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) is a neurodegenerative disorder with multifactorial etiology, including genetic factors that play a significant role in disease risk and resilience. However, the role of genetic diversity in preclinical AD studies...
